Covered recipient · General Payments record
JACK ELLIS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,158.85
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.56 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $72.14 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $60.53 | 2 |
| ABBVIE INC. | $40.28 | 2 |
| Janssen Pharmaceuticals, Inc | $36.67 | 2 |
| Lexicon Pharmaceuticals, Inc. | $21.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.47 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103688056 | CMS |
| ABBVIE INC. | $20.81 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103688058 | CMS |
| Janssen Pharmaceuticals, Inc | $17.12 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077988352 | CMS |
| Janssen Pharmaceuticals, Inc | $19.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077988406 | CMS |
| Lexicon Pharmaceuticals, Inc. | $21.94 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081700127 | CMS |
| Novartis Pharmaceuticals Corporation | $26.69 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086939625 | CMS |
| Novartis Pharmaceuticals Corporation | $33.84 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086939633 | CMS |
| PFIZER INC. | $18.55 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131279400 | CMS |
| PFIZER INC. | $22.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131439432 | CMS |
| PFIZER INC. | $15.35 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131853859 | CMS |
| PFIZER INC. | $15.25 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131489221 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.